Cargando…

What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study

BACKGROUND: It is unclear what to do when people with type 2 diabetes have had no or a limited glycemic response to a recently introduced medication. Intra-individual HbA1c variability can obscure true response. Some guidelines suggest stopping apparently ineffective therapy, but no studies have add...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGovern, Andrew P., Dennis, John M., Shields, Beverley M., Hattersley, Andrew T., Pearson, Ewan R., Jones, Angus G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460517/ https://www.ncbi.nlm.nih.gov/pubmed/30979373 http://dx.doi.org/10.1186/s12916-019-1307-8

Ejemplares similares

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?
por: Jones, Angus G., et al.
Publicado: (2016)

The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
por: Young, Katherine G., et al.
Publicado: (2022)

Correction to: The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
por: Young, Katherine G., et al.
Publicado: (2023)

Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort Study
por: Eibich, Peter, et al.
Publicado: (2017)

Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study
por: Donnelly, Louise A., et al.
Publicado: (2020)

TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol
por: Angwin, Catherine, et al.
Publicado: (2020)

Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes
por: Rodgers, Lauren R, et al.
Publicado: (2017)

Use of HbA1c in the Identification of Patients with Hyperglycaemia Caused by a Glucokinase Mutation: Observational Case Control Studies
por: Steele, Anna M., et al.
Publicado: (2013)

Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study
por: Rodgers, Lauren R., et al.
Publicado: (2021)

Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation
por: McGovern, Andrew P, et al.
Publicado: (2020)

HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study
por: Niwaha, Anxious J, et al.
Publicado: (2021)

Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017
por: Dennis, John M., et al.
Publicado: (2019)

Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach
por: Dennis, John M, et al.
Publicado: (2018)

Midsummer mysteries: Criminal masterminds? Not really…
por: Antonella Del Rosso
Publicado: (2014)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Selective Phenotyping, Entropy Reduction, and the Mastermind game
por: Gagneur, Julien, et al.
Publicado: (2011)

Felix Berezin: Life and death of the mastermind of supermathematics
por: Shifman, M, et al.
Publicado: (2007)

A View Beyond HbA1c: Role of Continuous Glucose Monitoring
por: Chehregosha, Haleh, et al.
Publicado: (2019)

When the Blood Glucose and the HbA(1c) Don’t Match: Turning Uncertainty Into Opportunity
por: Cohen, Robert M., et al.
Publicado: (2012)

MON-086 Various Subcutaneous Continuous Glucose Monitors Comparably Lower HbA1c in Children
por: Gold, Steven, et al.
Publicado: (2020)

HbA(1c): The lower the better?
por: Araki, Eiichi, et al.
Publicado: (2011)

Predictors of HbA(1c) treatment response to add-on medication following metformin monotherapy: a population-based cohort study
por: Tan, Wei Ying, et al.
Publicado: (2023)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Haemoglobin J-Baltimore can be detected by HbA(1c) electropherogram but with underestimated HbA(1c) value
por: Brunel, Valéry, et al.
Publicado: (2016)

Associations between HbA(1c) and continuous glucose monitoring‐derived glycaemic variables
por: Hirsch, I. B., et al.
Publicado: (2019)

Masterminds of programming: conversations with the creators of major programming languages
por: Biancuzzi, Federico, et al.
Publicado: (2009)

Securing Office 365: masterminding MDM and compliance in the cloud
por: Katzer, Matthew
Publicado: (2018)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Feng, Xiaojing, et al.
Publicado: (2021)

Hb H Interference on Measurement Of HbA1c With Ion-Exchange HPLC
por: Agilli, Mehmet, et al.
Publicado: (2013)

Haemoglobin switching modulator SNPs rs5006884 is associated with increased HbA(2) in β-thalassaemia carriers
por: Cyrus, Cyril, et al.
Publicado: (2019)

Drugs affecting HbA1c levels
por: Unnikrishnan, Ranjit, et al.
Publicado: (2012)

Current Status of HbA1c Biosensors
por: Lin, Hua, et al.
Publicado: (2017)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
por: Nasir, Nadzimah Mohd, et al.
Publicado: (2010)

In-House Algorithm for Reporting Discrepant HbA1c Result and Troubleshooting a Case of False Low HbA1c
por: Pant, Vivek, et al.
Publicado: (2021)

Estimation of mean erythrocyte age using HbA1c or HbA1c/glycated albumin for evaluation of anemia severity
por: Koga, Masafumi, et al.
Publicado: (2023)

Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
por: Shields, Beverley M, et al.
Publicado: (2023)

Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years
por: Lynam, Anita, et al.
Publicado: (2019)

Mastermind-Like 1 Is Ubiquitinated: Functional Consequences for Notch Signaling
por: Farshbaf, Mozhgan, et al.
Publicado: (2015)

CNTO 530 Increases Expression of HbA and HbF in Murine Models of β-Thalassemia and Sickle Cell Anemia
por: Makropoulos, Dorie A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fmu37667c8s4p75tumtj8vgib3